PASG Passage BIO, Inc.
Nasdaq · SEC CIK 1787297 · EDGAR
- Bought, last 12 months
- $206.1K 1 purchases by 1 insiders
- Sold, last 12 months
- $113.2K 2 sales by 2 insiders
- Filings on record
- 113 since 2021-07-21, latest 2026-06-29 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lynx1 Capital Management LP | 10% | $206.1K | — |
| Chou William | Pres AND CEO, Dir | — | $75.2K |
| Borthwick Kathleen | CFO | — | $38.0K |
Transactions 50
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-06-29 16:30 | 2026-06-25 | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $4.12 | +50.1K | 673.8K | +8% | +$206.1K |
| D | 2026-01-12 | 2026-01-08 | PASG | Borthwick Kathleen | CFO | M - OptEx | — | +5,000 | 7,464 | +203% | — |
| D | 2026-01-12 | 2026-01-08 | PASG | Borthwick Kathleen | CFO | S - Sale+OE | $18.44 | -2,062 | 5,402 | -28% | -$38.0K |
| D | 2026-01-12 | 2026-01-08 | PASG | Chou William | Pres AND CEO, Dir | M - OptEx | — | +10.0K | 10.6K | +1,667% | — |
| D | 2026-01-12 | 2026-01-08 | PASG | Chou William | Pres AND CEO, Dir | S - Sale+OE | $18.44 | -4,076 | 6,524 | -38% | -$75.2K |
| MI | 2025-09-15 | 2025-09-11+ | PASG | Nichols Weston | 10% | P - Purchase | $6.99 | +32.0K | 611.8K | +6% | +$223.7K |
| MI | 2025-07-24 | 2025-07-22+ | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $5.69 | +128.8K | 525.3K | +33% | +$733.7K |
| MI | 2025-06-26 | 2025-06-24+ | PASG | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.3379 | -583.7K | 6.28M | -9% | -$197.2K |
| MI | 2025-04-24 | 2025-04-22+ | PASG | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.3342 | -235.6K | 6.81M | -3% | -$78.7K |
| MI | 2025-04-17 | 2025-04-15+ | PASG | OrbiMed Capital GP VII LLC | 10% | S - Sale | $0.3335 | -149.1K | 6.89M | -2% | -$49.7K |
| D | 2025-02-12 | 2025-02-10 | PASG | Borthwick Kathleen | CFO | M - OptEx | — | +8,000 | 44.5K | +22% | — |
| D | 2025-02-12 | 2025-02-11 | PASG | Borthwick Kathleen | CFO | S - Sale+OE | $0.53 | -3,183 | 41.3K | -7% | -$1,687 |
| MI | 2025-01-14 | 2025-01-10+ | PASG | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.6371 | -223.2K | 7.03M | -3% | -$142.2K |
| MI | 2025-01-08 | 2025-01-06+ | PASG | OrbiMed Capital GP VII LLC | 10% | S - Sale | $0.7026 | -147.0K | 7.26M | -2% | -$103.3K |
| I | 2024-12-31 | 2024-12-27 | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $0.65 | +373.6K | 9.26M | +4% | +$242.9K |
| I | 2024-12-26 | 2024-12-20 | PASG | OrbiMed Capital GP VII LLC | 10% | S - Sale | $0.6 | -230.3K | 7.40M | -3% | -$138.2K |
| MI | 2024-12-11 | 2024-12-09+ | PASG | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.8348 | -62.3K | 7.64M | -0.8% | -$52.0K |
| MI | 2024-12-06 | 2024-12-04+ | PASG | OrbiMed Capital GP VII LLC | 10% | S - Sale | $0.7965 | -97.1K | 7.70M | -1% | -$77.3K |
| MI | 2024-11-27 | 2024-11-25+ | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $0.622 | +456.4K | 8.85M | +5% | +$283.8K |
| I | 2024-09-23 | 2024-09-19 | PASG | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.71 | -39.3K | 7.79M | -0.5% | -$27.9K |
| MI | 2024-09-18 | 2024-09-16+ | PASG | OrbiMed Capital GP VII LLC | 10% | S - Sale | $0.7332 | -200.1K | 7.86M | -2% | -$146.7K |
| D | 2024-02-13 | 2024-02-13 | PASG | Forman Mark S | Chief MEDICAL Off | S - Sale+OE | $0.97 | -1,638 | 48.6K | -3% | -$1,589 |
| D | 2024-02-13 | 2024-02-10 | PASG | Forman Mark S | Chief MEDICAL Off | M - OptEx | — | +5,000 | 50.3K | +11% | — |
| D | 2024-02-13 | 2024-02-10 | PASG | Borthwick Kathleen | SVP, INTERIM CFO | M - OptEx | — | +4,000 | 29.9K | +15% | — |
| D | 2024-02-13 | 2024-02-13 | PASG | Borthwick Kathleen | SVP, INTERIM CFO | S - Sale+OE | $0.97 | -1,470 | 28.5K | -5% | -$1,426 |
| D | 2024-01-03 | 2023-12-31 | PASG | Cale Edgar B. | GC, Corp. Sec | M - OptEx | — | +50.0K | 61.8K | +423% | — |
| D | 2024-01-03 | 2024-01-02 | PASG | Cale Edgar B. | GC, Corp. Sec | S - Sale+OE | $0.91 | -15.8K | 46.0K | -26% | -$14.4K |
| D | 2024-01-03 | 2023-12-31 | PASG | Forman Mark S | Chief Medical Off | M - OptEx | — | +50.0K | 61.1K | +451% | — |
| D | 2024-01-03 | 2024-01-02 | PASG | Forman Mark S | Chief Medical Off | S - Sale+OE | $0.91 | -15.8K | 45.3K | -26% | -$14.4K |
| D | 2024-01-03 | 2024-01-02 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.91 | -10.7K | 25.9K | -29% | -$9,712 |
| D | 2024-01-03 | 2023-12-31 | PASG | Borthwick Kathleen | SVP, Interim CFO | M - OptEx | — | +30.0K | 36.6K | +454% | — |
| D | 2023-08-01 | 2023-07-28 | PASG | King Simona | CFO | M - OptEx | $0.00 | +31.2K | 35.4K | +745% | $0 |
| D | 2023-08-01 | 2023-07-28 | PASG | King Simona | CFO | S - Sale+OE | $0.88 | -11.5K | 24.0K | -32% | -$10.1K |
| MI | 2023-06-29 | 2023-06-27+ | PASG | ORBIMED ADVISORS LLC | 10% | P - Purchase | $0.84 | +1.19M | 8.03M | +17% | +$1.00M |
| D | 2023-06-20 | 2023-06-16 | PASG | Fotopoulos Alexandros | Chief Technical Off | S - Sale+OE | $0.93 | -4,052 | 28.7K | -12% | -$3,768 |
| D | 2023-06-20 | 2023-06-15 | PASG | Fotopoulos Alexandros | Chief Technical Off | M - OptEx | $0.00 | +12.5K | 32.7K | +62% | $0 |
| D | 2023-04-20 | 2023-04-18 | PASG | King Simona | CFO | M - OptEx | $0.00 | +6,250 | 6,250 | New | $0 |
| D | 2023-04-20 | 2023-04-18 | PASG | King Simona | CFO | S - Sale+OE | $1.05 | -2,053 | 2,053 | -50% | -$2,156 |
| 2022-12-02 | 2022-12-01 | PASG | Kapadia Sandip | Dir | S - Sale | $1.19 | -5,000 | 0 | -100% | -$5,950 | |
| D | 2022-11-25 | 2022-11-22 | PASG | Fotopoulos Alexandros | Chief Technical Off | M - OptEx | $0.00 | +12.5K | 24.0K | +109% | $0 |
| D | 2022-11-25 | 2022-11-22 | PASG | Fotopoulos Alexandros | Chief Technical Off | S - Sale+OE | $1.33 | -3,720 | 20.2K | -16% | -$4,948 |
| D | 2022-11-18 | 2022-09-15 | PASG | Toernsen Monika Maria | Chief Commercial Off | M - OptEx | — | +5,000 | 5,000 | New | — |
| D | 2022-11-18 | 2022-09-19 | PASG | Toernsen Monika Maria | Chief Commercial Off | S - Sale+OE | $1.51 | -1,681 | 3,319 | -34% | -$2,538 |
| AI | 2022-05-05 | 2022-01-20 | PASG | ORBIMED ADVISORS LLC | 10% | P - Purchase | $5.00 | +50.8K | 6.32M | +0.8% | +$254.0K |
| MI | 2022-05-05 | 2022-05-03+ | PASG | OrbiMed Capital GP VII LLC | 10% | P - Purchase | $1.94 | +525.0K | 6.84M | +8% | +$1.02M |
| 2022-03-23 | 2022-03-21 | PASG | Goldsmith Bruce A | CEO, Pres, Dir | P - Purchase | $3.15 | +10.0K | 16.0K | +167% | +$31.5K | |
| I | 2022-01-24 | 2022-01-20 | PASG | OrbiMed Capital GP VII LLC | 10% | P - Purchase | $5.42 | +369.1K | 6.63M | +6% | +$2.00M |
| MI | 2022-01-20 | 2022-01-14+ | PASG | OrbiMed Capital GP VII LLC | 10% | P - Purchase | $5.38 | +168.3K | 6.27M | +3% | +$905.2K |
| MI | 2022-01-13 | 2022-01-11+ | PASG | OrbiMed Capital GP VII LLC | 10% | P - Purchase | $5.61 | +150.0K | 6.06M | +3% | +$841.1K |
| D | 2021-12-10 | 2021-12-08 | PASG | Quigley Jill M. | COO | M - OptEx | $0.23 | +72.0K | 368.8K | +24% | +$16.6K |